NLM Logo

AB-triple V protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
AB-triple V protocol
Unique ID
C060275
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C060275
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine / *analogs & derivatives
Etoposide
Vinblastine
Vincristine
Aclarubicin
Frequency
2
Note
chemotherapy protocol used in treatment of acute myelogenous leukemia; consists of aclarubicin, behenoyl ara-C, etoposide, vincristine, & vinblastine or vindesine; use MH VINDESINE also when needed
Source
Rinsho Ketsueki 1989;30(2):169
Date of Entry
1989/08/16
Revision Date
2013/11/06
AB-triple V protocol Preferred
page delivered in 0.004s